Hypothalamus hormone production
Hypothalamus hormone production

Cushing’s syndrome - exogenous

Definition:

Exogenous Cushing's syndrome is a form of Cushing's syndrome caused by administration of glucocorticoid (also called corticosteroid) hormones, such as prednisone.



Alternative Names:
Cushing's syndrome - corticosteroid induced; Corticosteroid-induced Cushing's syndrome; Iatrogenic Cushing's syndrome

Causes, incidence, and risk factors:

Cushing's syndrome is named after the surgeon Harvey Cushing. It is a group of clinical signs and symptoms caused by a chronic excess of glucocorticoids, which are hormones produced by the adrenal glands. Glucocorticoids affect many body functions and are essential for survival, but when the level of these hormones is too high, it can cause serious problems. The most important glucocorticoid is the "stress hormone" cortisol.

The pituitary gland, a small gland at the base of the brain, regulates cortisol production by secreting a hormone called adrenocorticotropic hormone (ACTH).

Exogenous (i.e., caused by something outside the body) Cushing's syndrome is caused by administration of synthetic glucocorticoids, such as prednisone or dexamethasone, for therapeutic purposes (for example, to treat asthma).

Endogenous (i.e., caused by something within the body) Cushing's syndrome may be caused by ACTH-producing tumors of the pituitary gland (a condition called Cushing's disease), malignant tumors of other organs that produce ACTH, and cortisol-producing tumors of one or both of the adrenal glands.
Symptoms:

Additional symptoms that may be associated with this disease:

Signs and tests:
  • current use of cortisone, prednisone or other corticosteroids
  • low or undetectable morning plasma ACTH level
  • low or undetectable morning plasma cortisol level
  • failure to respond to a Cosyntropin stimulation test
  • low free cortisol level if measured in the urine
  • high levels of the offending medication in the urine if measured by a special technique called high performance liquid chomatography (HPLC)
  • fasting glucose is sometimes elevated
  • serum potassium may be low
  • low bone mineral density as measure by dual X-ray absortiometry (DEXA)
  • high cholesterol, particularly high triglycerides and low high density lipoprotein (HDL)
Treatment:

The suggested treatment is slow withdrawal of corticosteroid therapy under medical supervision. In situations where the medication cannot be discontinued because of the underlying disease (for example, if steroids are needed to treat severe asthma), every effort should be made to reduce the possibilty of developing complications.

Excess glucocortoids can raise blood sugar and cholesterol levels, and increase bone loss.

  • High blood sugar should be treated aggressively with diet, oral medications, and/or insulin
  • High cholesterol should be treated with diet and/or medications
  • Most experts recommend treating patients who will be on steroids for longer than 4-6 weeks in with medication to prevent bone loss (e.g., bisphosphonates like alendronate or risedronate). This will reduce the risk of fracture.
Expectations (prognosis):

The effects of adrenal atrophy caused by chronic drug administration should be reversible by withdrawing the drug.

Complications:
  • Cushing's syndrome symptoms can cause persistent discomfort.
  • Steroids can cause diabetes and high cholesterol levels. If left untreated, both of these complications can increase the risk of heart attacks. Untreated high blood sugar over many years can cause damage to the eyes, kidneys and nerves.
  • Cushing's syndrome can also lead to weak bones (osteoporosis) and increase the risk of fracture.
These complications can generally be prevented with proper treatment.
Calling your health care provider:

Call for an appointment with your health care provider if you are taking a corticosteroid drug and you develop symptoms of Cushing's syndrome.

Prevention:

Awareness of the signs and symptoms of Cushing's syndrome may permit early intervention for patients prescribed corticosteroids.


Review Date: 11/3/2002
Reviewed By: Todd T. Brown, M.D., Division of Endocrinology and Metabolism, Johns Hopkins Hospital, Baltimore, MD. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.